Press and Announcements

Praetego’s progress is routinely updated as we strive to enter clinical trials.
Please check back frequently for news, announcements, and events.



urpose Praetego was founded on rigorous and extensive science and the desire to offer a potent oral drug for neurodegenerative diseases associated with aging. Our proprietary small molecule technology inhibits an established driver of disease pathology in neurodegeneration, diabetic microvascular disease, and aging. Read More >